Organon (OGN) Revenue (2020 - 2026)

Organon has reported Revenue for 7 years, with the latest figure at $1.6 billion in Q2 2026.

• On a quarterly basis, Revenue fell 2.26% year-over-year to $1.6 billion in Q2 2026; TTM through Jun 2026 was $6.1 billion, a 2.45% decrease from a year earlier, with the FY2025 full-year figure at $6.2 billion, down 2.92% from the prior year.
• Revenue was $1.6 billion for Q2 2026 at Organon, up from $1.5 billion in the prior quarter.
• The five-year high for Revenue was $1.6 billion in Q1 2024, with the low at $1.5 billion in Q1 2026.
• Average Revenue over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2022.
• The sharpest annual moves came in 2022 and 2023: Revenue slipped 7.36% in 2022, then rose 7.61% in 2023.
• Over 5 years, Revenue stood at $1.5 billion in 2022, then climbed by 7.61% to $1.6 billion in 2023, then retreated by 0.38% to $1.6 billion in 2024, then slipped by 5.34% to $1.5 billion in 2025, then advanced by 3.38% to $1.6 billion in 2026.
• The last three Revenue figures came in at $1.6 billion (Q2 2026), $1.5 billion (Q1 2026), and $1.5 billion (Q4 2025), per Business Quant data.